Literature DB >> 19725066

The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron.

Ying T Mak1, Wai P Lam, Lanhai Lü, Yeuk W Wong, David T Yew.   

Abstract

Ketamine used as an injectable anesthetic in human and animal medicine is also a recreational drug used primarily by young adults often at all night dance parties in nightclubs. The percentage of ketamine users has grown very fast in the last 5 years worldwide. However, this leads to the serious question of the long-term adverse effects of ketamine on our nervous system, particularly the brain, because ketamine as an NMDA antagonist could cause neurons to commit apoptosis. Our study therefore aimed to find out the chronic effect of ketamine on neuron using prolonged incubation (48 h) of neuronal cells with ketamine in culture. Our results showed that differentiated neuronal cells were prone to the toxicity of ketamine but probably less susceptible than undifferentiated neuronal cells and fibroblasts. This suggested that the ketamine abuse would be harmful to many other organs as well as the brain. Our results also confirmed that the toxicity of ketamine is related to apoptosis via the Bax/Bcl-2 ratio pathway and caspase-3 in the differentiated neuronal cells. Therefore, long-term ketamine treated cell or animal models should be sought to study this multiorgan effects of ketamine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19725066     DOI: 10.1002/jemt.20774

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  15 in total

1.  Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway.

Authors:  Zeljko J Bosnjak; Yasheng Yan; Scott Canfield; Maria Y Muravyeva; Chika Kikuchi; Clive W Wells; John A Corbett; Xiaowen Bai
Journal:  Curr Drug Saf       Date:  2012-04

2.  Chronic ketamine administration modulates midbrain dopamine system in mice.

Authors:  Sijie Tan; Wai Ping Lam; Maria S M Wai; Wan-Hua Amy Yu; David T Yew
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 3.  Modeling anesthetic developmental neurotoxicity using human stem cells.

Authors:  Xiaowen Bai; Danielle Twaroski; Zeljko J Bosnjak
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2013-07-16

4.  Zoletil promotes apoptosis in BV-2 microglial cells via induction of oxidative stress and neural inflammation.

Authors:  Gyun Moo Kim; Chan Lee; Tae Chang Jang
Journal:  Toxicol Res (Camb)       Date:  2021-12-29       Impact factor: 3.524

5.  Inhibition of GSK-3beta Signaling Pathway Rescues Ketamine-Induced Neurotoxicity in Neural Stem Cell-Derived Neurons.

Authors:  Jingjing Zhang; Changlei Cui; Yanhui Li; Haiyang Xu
Journal:  Neuromolecular Med       Date:  2017-12-07       Impact factor: 3.843

Review 6.  Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience.

Authors:  Brad J Kolls; Yasmin A O'Keefe; Alok K Sahgal
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

7.  Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway.

Authors:  Xiaowen Bai; Yasheng Yan; Scott Canfield; Maria Y Muravyeva; Chika Kikuchi; Ivan Zaja; John A Corbett; Zeljko J Bosnjak
Journal:  Anesth Analg       Date:  2013-03-04       Impact factor: 5.108

8.  Brain damages in ketamine addicts as revealed by magnetic resonance imaging.

Authors:  Chunmei Wang; Dong Zheng; Jie Xu; Waiping Lam; D T Yew
Journal:  Front Neuroanat       Date:  2013-07-17       Impact factor: 3.856

9.  Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice.

Authors:  Sijie Tan; John A Rudd; David T Yew
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

10.  Ketamine as antidepressant? Current state and future perspectives.

Authors:  H W W Hasselmann
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.